PMC:7299399 / 47988-48126
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T432 | 115-117 | http://purl.obolibrary.org/obo/CLO_0007622 | denotes | MD |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T400 | 78-82 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T401 | 83-92 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T402 | 115-117 | Chemical | denotes | MD | http://purl.obolibrary.org/obo/CHEBI_74699 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T186 | 0-114 | Sentence | denotes | Figure 3 Schematic of how in silico analysis can be used to select candidate drug molecules for clinical studies. |
| T187 | 115-138 | Sentence | denotes | MD, molecular dynamics. |